Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®.
Bioorg Med Chem Lett
; 29(16): 2415-2427, 2019 08 15.
Article
in En
| MEDLINE
| ID: mdl-31230974
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Protease Inhibitors
/
Carbamates
/
Viral Nonstructural Proteins
/
Hepacivirus
/
Drug Discovery
/
Heterocyclic Compounds, 4 or More Rings
Limits:
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2019
Document type:
Article
Country of publication:
Reino Unido